Bayer Falls Short in Bid to Beat Eliquis in Afib, But Key Stroke Study Continues

Retrieved on: 2023-11-20 17:41:23

Tags for this article:

Click the tags to see associated articles and topics

Bayer Falls Short in Bid to Beat Eliquis in Afib, But Key Stroke Study Continues. View article details on hiswai:

Excerpt

An independent data monitoring committee concluded Bayer's experimental drug for atrial fibrillation would not be more effective than Eliquis, ...

Article found on: medcitynews.com